DIN 02533030 — SOTYKTU 6 MG
SOTYKTU is a tablet of Deucravacitinib marketed by BRISTOL-MYERS SQUIBB CANADA. The full Deucravacitinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02533030
- Brand name
- SOTYKTU
- Active ingredient
- Deucravacitinib
- Strength
- 6 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Tyrosine kinase 2 (TYK2) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.